A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber

Summary

This trial evaluates the efficacy and safety of HDM SLIT-tablet in treatment of HDM AR. The efficacy is evaluated using an environmental exposure chamber (EEC). Subjects will be randomised to receive treatment with HDM SLIT-tablet and placebo 1:1.

Timeline

Start

2019-11-04

Primary completion

2019-12-17

Completion

2022-01-19

Outcome

Outcome not reported

Stopped: “COVID-19”

Drugs

Indications